Pharma Regulatory Management Systems Market by Component (Services, Solution), Deployment (On-Cloud, On-Premises), End User - Global Forecast 2024-2030

Pharma Regulatory Management Systems Market by Component (Services, Solution), Deployment (On-Cloud, On-Premises), End User - Global Forecast 2024-2030


The Pharma Regulatory Management Systems Market size was estimated at USD 1.02 billion in 2023 and expected to reach USD 1.16 billion in 2024, at a CAGR 14.52% to reach USD 2.63 billion by 2030.

Global Pharma Regulatory Management Systems Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharma Regulatory Management Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharma Regulatory Management Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharma Regulatory Management Systems Market, highlighting leading vendors and their innovative profiles. These include Antares Vision S.p.A., ArisGlobal LLC, arivis AG by Carl Zeiss AG, Dassault Systèmes S.E., DDi Smart Technology, Dovel Group, Ennov Group, EXTEDO GmbH, Freyr Software Services Pvt. Ltd., Informa PLC, Instem PLC, IQVIA Inc., MasterControl Inc., NNIT GROUP, pharmaREADY by Navitas Life Sciences, and Veeva Systems Inc..

Market Segmentation & Coverage

This research report categorizes the Pharma Regulatory Management Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

Component
Services
Managed Services
Professional Services
Solution
IDMP/Compliance Management
Regulatory Information Management
Regulatory Submissions Management System
Deployment
On-Cloud
On-Premises
End User
Government Agencies
Hospitals & Care Providers
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Pharma Regulatory Management Systems Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharma Regulatory Management Systems Market?
3. What are the technology trends and regulatory frameworks in the Pharma Regulatory Management Systems Market?
4. What is the market share of the leading vendors in the Pharma Regulatory Management Systems Market?
5. Which modes and strategic moves are suitable for entering the Pharma Regulatory Management Systems Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Pharma Regulatory Management Systems Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Strengthening the regulatory scenario in the pharmaceutical industry
5.1.1.2. Increased focus on reducing manual efforts and errors
5.1.1.3. Demand for streamline the data of medical products and devices
5.1.2. Restraints
5.1.2.1. High cost of implementation and training at administrative side
5.1.3. Opportunities
5.1.3.1. Innovation in software with improved process to assure effective management of regulatory information
5.1.3.2. Increasing pharma business expansion in different regulatory territories
5.1.4. Challenges
5.1.4.1. Constantly evolving the regulatory landscape
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Pharma Regulatory Management Systems Market, by Component
6.1. Introduction
6.2. Services
6.3.1. Managed Services
6.3.2. Professional Services
6.3. Solution
6.4.1. IDMP/Compliance Management
6.4.2. Regulatory Information Management
6.4.3. Regulatory Submissions Management System
7. Pharma Regulatory Management Systems Market, by Deployment
7.1. Introduction
7.2. On-Cloud
7.3. On-Premises
8. Pharma Regulatory Management Systems Market, by End User
8.1. Introduction
8.2. Government Agencies
8.3. Hospitals & Care Providers
8.4. Pharmaceutical & Biotechnology Companies
9. Americas Pharma Regulatory Management Systems Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pharma Regulatory Management Systems Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Pharma Regulatory Management Systems Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Antares Vision S.p.A.
13.1.2. ArisGlobal LLC
13.1.3. arivis AG by Carl Zeiss AG
13.1.4. Dassault Systèmes S.E.
13.1.5. DDi Smart Technology
13.1.6. Dovel Group
13.1.7. Ennov Group
13.1.8. EXTEDO GmbH
13.1.9. Freyr Software Services Pvt. Ltd.
13.1.10. Informa PLC
13.1.11. Instem PLC
13.1.12. IQVIA Inc.
13.1.13. MasterControl Inc.
13.1.14. NNIT GROUP
13.1.15. pharmaREADY by Navitas Life Sciences
13.1.16. Veeva Systems Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET RESEARCH PROCESS
FIGURE 2. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, 2023 VS 2030
FIGURE 3. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET DYNAMICS
FIGURE 7. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 8. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
FIGURE 10. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PHARMA REGULATORY MANAGEMENT SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings